Multicenter, Open-Label, 2-Arm, Pilot Trial for Safe Reduction of Basal Insulin Dose Combined with SGLT2 Inhibitor in Type 1 Diabetes Mellitus: Study Protocol for a RISING-STAR Trial

BACKGROUND: The safe method of instructing insulin dose reduction in combination with SGLT2 inhibitors, dapagliflozin for patients with type 1 diabetes mellitus has not been clarified. In this study, we conducted a stratified, 2-arm, parallel comparative study with the primary endpoint of decreasing...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamaguchi, Masahide, Hashimoto, Yoshitaka, Tanaka, Toru, Hasegawa, Goji, Ishii, Michiyo, Okada, Hiroshi, Mitsuhashi, Kazuteru, Kitagawa, Noriyuki, Ushigome, Emi, Yamazaki, Masahiro, Fukui, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482353/
https://www.ncbi.nlm.nih.gov/pubmed/34602832
http://dx.doi.org/10.1177/11795514211040539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482353/
https://www.ncbi.nlm.nih.gov/pubmed/34602832
http://dx.doi.org/10.1177/11795514211040539

Ejemplares similares